Doctoral students and young scientists of the Centre for Experimental Medicine of the Slovak Academy of Sciences (CEM SAS) organised the first of a series of seminars where they presented the results of their research.
Ing. Marek Lepáček, a PhD student at the Institute of Experimental Pharmacology and Toxicology of CEM SAV, started the series of seminars. On 23 March, he presented to his colleagues the interaction of intestinal microflora and a new aldose reductase inhibitor cemtirestat in ZDF rats.
The next workshop will be held on 18 April, where Mgr. Adam Kubinec from the Institute of Normal and Pathological Physiology CEM SAS.
